Gravel R A, Triggs-Raine B L, Mahuran D J
McGill University-Montreal Children's Hospital Research Institute, Quebec, Canada.
Can J Neurol Sci. 1991 Aug;18(3 Suppl):419-23. doi: 10.1017/s0317167100032583.
Tay-Sachs disease is one of the few neurodegenerative diseases of known causes. It results from mutations of the HEXA gene encoding the alpha subunit of beta-hexosaminidase, producing a destructive ganglioside accumulation in lysosomes, principally in neurons. With the determination of the protein sequence of the alpha and beta subunits, deduced from cDNA sequences, the complex pathway of subcellular and lysosomal processing of the enzyme has been determined. More recently, detailed knowledge of the gene structure has allowed the determination of specific mutations causing Tay-Sachs disease. The high incidence of the disease in Ashkenazi Jews is attributed predominantly to three mutations present in high frequency, while in non-Jews some two dozen mutations have been identified thus far. The cataloguing of mutations has important implications for carrier screening and prenatal diagnosis for Tay-Sachs disease.
泰-萨克斯病是少数几种病因明确的神经退行性疾病之一。它是由编码β-己糖胺酶α亚基的HEXA基因突变引起的,导致溶酶体中主要在神经元内产生具有破坏性的神经节苷脂积累。随着从cDNA序列推导得出的α和β亚基蛋白质序列的确定,该酶的亚细胞和溶酶体加工的复杂途径已被确定。最近,对基因结构的详细了解使得能够确定导致泰-萨克斯病的特定突变。阿什肯纳兹犹太人中该病的高发病率主要归因于三种高频出现的突变,而在非犹太人中,迄今为止已鉴定出约二十多种突变。突变的编目对泰-萨克斯病的携带者筛查和产前诊断具有重要意义。